If you are considering joining the 2 million people in the U.S. taking a prescription weight loss medication such as Ozempic ...
The federal agency’s new alert is about counterfeit drugs claiming to have semaglutide — the key ingredient in weight loss ...
Wegovy contains the same main ingredient as Ozempic, semaglutide, and is FDA-approved for weight loss in people with obesity or who are overweight with at least one weight-related condition. It is ...
Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...
Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...
Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...
After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...
To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...
FDA ends GLP-1 drug shortage. Concerns over safety, counterfeit drugs, and high cost of brand-name versions persist; ...
These medications are not FDA-approved, meaning they do not undergo the rigorous testing for safety, effectiveness, and ...
Illegal networks are flooding the market with counterfeit weight loss drugs, posing a serious threat to public health. The ...
Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...